Autopsy report · NCT02679430
Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres
Cause of deathRegulatory or ethics
“The study was deferred and never approved by the Maimonides Medical Center IRB.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Antonios Likourezos
- Sponsor type
- University, hospital or other
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Prostate Arterial Embolization
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.” - Needle-X: Usability Testing of a Smartphone Application
“The study was never started by the responsible party (medical student who is no longer at the institution).” - Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
“This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .” - Non-antibiotic Management in Acute Uncomplicated Diverticulitis
“Study was never approved by the institutional review board.” - Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
“The study was never initiated, no patients were enrolled. It has been closed with the IRB.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.